• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超重和肥胖与静脉血栓栓塞事件风险的关系:特罗姆瑟研究。

The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromsø Study.

机构信息

Thrombosis Research Group, Department of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway.

Division of Internal Medicine, Thrombosis Research Center, University Hospital of North Norway, Tromsø, Norway.

出版信息

Thromb Haemost. 2024 Mar;124(3):239-249. doi: 10.1055/s-0043-1772212. Epub 2023 Aug 7.

DOI:10.1055/s-0043-1772212
PMID:37549694
Abstract

BACKGROUND

Obesity is a well-established risk factor for venous thromboembolism (VTE). However, data on the proportion of incident VTEs attributed to overweight and obesity in the general population are limited.

OBJECTIVE

To investigate the population attributable fraction (PAF) of VTE due to overweight and obesity in a population-based cohort with repeated measurements of body mass index (BMI).

METHODS

Participants from the fourth to seventh surveys of the Tromsø Study (enrolment: 1994-2016) were followed through 2020, and all incident VTEs were recorded. In total, 36,341 unique participants were included, and BMI measurements were updated for those attending more than one survey. BMI was categorized as <25 kg/m, 25-30 kg/m (overweight), and ≥30 kg/m (obesity). Time-varying Cox regression models were used to calculate hazard ratios (HRs) with 95% confidence intervals (CIs). The PAF was estimated based on age- and sex-adjusted HRs and the prevalence of BMI categories in VTE cases.

RESULTS

At baseline, the prevalence of overweight and obesity was 37.9 and 13.8%, respectively. During a median follow-up of 13.9 years, 1,051 VTEs occurred. The age- and sex-adjusted HRs of VTE were 1.40 (95% CI: 1.21-1.61) for overweight and 1.86 (95% CI: 1.58-2.20) for obesity compared with subjects with BMI <25 kg/m. The PAF of VTE due to overweight and obesity was 24.6% (95% CI: 16.6-32.9), with 12.9% (95% CI: 6.6-19.0) being attributed to overweight and 11.7% (95% CI: 8.5-14.9) to obesity. Similar PAFs were obtained in analyses stratified by sex and VTE subtypes (provoked/unprovoked events, deep vein thrombosis, pulmonary embolism).

CONCLUSION

Our findings indicate that almost 25% of all VTE events can be attributed to overweight and obesity in a general population from Norway.

摘要

背景

肥胖是静脉血栓栓塞症(VTE)的一个公认的危险因素。然而,关于普通人群中超重和肥胖导致的 VTE 比例的数据有限。

目的

在一个基于人群的队列中,通过对体重指数(BMI)进行重复测量,研究 VTE 归因于超重和肥胖的人群归因分数(PAF)。

方法

来自特罗姆瑟研究第四次至第七次调查(入组时间:1994-2016 年)的参与者在 2020 年之前进行了随访,所有新发 VTE 均被记录。共有 36341 名独特的参与者被纳入研究,对于参加过一次以上调查的参与者,更新了 BMI 测量值。BMI 分为<25kg/m、25-30kg/m(超重)和≥30kg/m(肥胖)。使用时间依赖性 Cox 回归模型计算危险比(HR)及其 95%置信区间(CI)。根据年龄和性别调整后的 HR 和 VTE 病例中 BMI 类别的患病率,估计 PAF。

结果

基线时,超重和肥胖的患病率分别为 37.9%和 13.8%。在中位随访 13.9 年期间,发生了 1051 例 VTE。与 BMI<25kg/m 的受试者相比,超重和肥胖的 VTE 年龄和性别调整后的 HR 分别为 1.40(95%CI:1.21-1.61)和 1.86(95%CI:1.58-2.20)。超重和肥胖导致 VTE 的 PAF 为 24.6%(95%CI:16.6-32.9),其中 12.9%(95%CI:6.6-19.0)归因于超重,11.7%(95%CI:8.5-14.9)归因于肥胖。在按性别和 VTE 亚型(诱发性/非诱发性事件、深静脉血栓形成、肺栓塞)分层的分析中,也得到了类似的 PAF。

结论

我们的研究结果表明,在挪威的普通人群中,近 25%的所有 VTE 事件可归因于超重和肥胖。

相似文献

1
The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromsø Study.超重和肥胖与静脉血栓栓塞事件风险的关系:特罗姆瑟研究。
Thromb Haemost. 2024 Mar;124(3):239-249. doi: 10.1055/s-0043-1772212. Epub 2023 Aug 7.
2
Cardiorespiratory fitness and future risk of venous thromboembolism.心肺适能与未来静脉血栓栓塞风险。
J Thromb Haemost. 2019 Dec;17(12):2160-2168. doi: 10.1111/jth.14619. Epub 2019 Sep 17.
3
Cardiovascular Risk Factors Associated With Venous Thromboembolism.心血管危险因素与静脉血栓栓塞症。
JAMA Cardiol. 2019 Feb 1;4(2):163-173. doi: 10.1001/jamacardio.2018.4537.
4
Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism.血浆纤溶酶原激活物抑制剂-1 水平升高与未来发生静脉血栓栓塞的风险相关。
J Thromb Haemost. 2022 Jul;20(7):1618-1626. doi: 10.1111/jth.15701. Epub 2022 Mar 25.
5
Venous thromboembolism and subsequent permanent work-related disability.静脉血栓栓塞症及随后的永久性与工作相关的残疾。
J Thromb Haemost. 2016 Oct;14(10):1978-1987. doi: 10.1111/jth.13411. Epub 2016 Aug 17.
6
The Risk of Venous Thromboembolism Attributed to Established Prothrombotic Genotypes.既定促血栓形成基因型所致静脉血栓栓塞风险。
Thromb Haemost. 2022 Jul;122(7):1221-1230. doi: 10.1055/a-1698-6717. Epub 2021 Nov 16.
7
Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study.事件性心肌梗死对静脉血栓栓塞风险的影响:特罗姆瑟研究。
J Thromb Haemost. 2016 Jun;14(6):1183-91. doi: 10.1111/jth.13329. Epub 2016 May 10.
8
Resting Heart Rate and Risk of Incident Venous Thromboembolism: The Tromsø Study.静息心率与静脉血栓栓塞事件风险:特罗姆瑟研究
Thromb Haemost. 2025 May 8. doi: 10.1055/a-2593-1679.
9
Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study.心肌梗死和肥胖对静脉血栓栓塞风险的联合影响:特罗姆瑟研究。
J Thromb Haemost. 2022 Oct;20(10):2342-2349. doi: 10.1111/jth.15812. Epub 2022 Jul 19.
10
Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the Tromsø Study.颈动脉粥样硬化的重复测量与静脉血栓栓塞的未来风险:特罗姆瑟研究。
J Thromb Haemost. 2017 Dec;15(12):2344-2351. doi: 10.1111/jth.13858. Epub 2017 Oct 27.

引用本文的文献

1
Metabolic syndrome, adipokines, coagulation factors, and venous thromboembolism: a two-step Mendelian randomization study.代谢综合征、脂肪因子、凝血因子与静脉血栓栓塞症:一项两步孟德尔随机化研究
Diabetol Metab Syndr. 2025 Jun 4;17(1):190. doi: 10.1186/s13098-025-01763-z.
2
Cohort Profile: - A Linkage Between Danish National Health Surveys and Health Registers.队列简介:丹麦国家健康调查与健康登记册之间的联系。
Clin Epidemiol. 2025 May 29;17:485-495. doi: 10.2147/CLEP.S522468. eCollection 2025.
3
Weighing the evidence on GLP1s and venous thromboembolism.
权衡有关胰高血糖素样肽-1(GLP1)与静脉血栓栓塞的证据。
Blood Adv. 2025 May 27;9(10):2458-2459. doi: 10.1182/bloodadvances.2025016052.
4
Causal relationship between chronic kidney disease, renal function, and venous thromboembolism: a bidirectional Mendelian randomization study.慢性肾脏病、肾功能与静脉血栓栓塞之间的因果关系:一项双向孟德尔随机化研究
Ren Fail. 2025 Dec;47(1):2496803. doi: 10.1080/0886022X.2025.2496803. Epub 2025 May 5.
5
The Association Between Chronotype and Weight Change Among Medical Students: A Cross-Sectional Study.医学生的昼夜节律类型与体重变化之间的关联:一项横断面研究。
Diabetes Metab Syndr Obes. 2025 Apr 16;18:1125-1136. doi: 10.2147/DMSO.S504151. eCollection 2025.
6
Venous thrombosis and obesity: from clinical needs to therapeutic challenges.静脉血栓形成与肥胖:从临床需求到治疗挑战
Intern Emerg Med. 2025 Jan;20(1):47-64. doi: 10.1007/s11739-024-03765-7. Epub 2024 Sep 13.
7
Emerging Medical Therapies for the Treatment of Obesity in Women with Cardiovascular Diseases.女性心血管疾病患者肥胖的新兴医学治疗方法。
Curr Cardiol Rep. 2023 Nov;25(11):1475-1488. doi: 10.1007/s11886-023-01961-z. Epub 2023 Oct 24.
8
Venous Thromboembolism and Obesity: Moving Toward a Better Understanding of the Population-Attributable Risk.静脉血栓栓塞与肥胖:迈向对人群归因风险的更好理解
Thromb Haemost. 2024 Mar;124(3):250-252. doi: 10.1055/s-0043-1776010. Epub 2023 Oct 9.